LEXARIA BIOSCIENCE CORP. (LEXX) Quick Ratio
- Quick ratio · latest quarter: Value 9.26×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31..
Quick ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 9.26× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31. $3.55M ÷ $383.41K ≈ 9.26× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 3.55M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 383.41K USD | Liabilities, Current |
| Cash and equivalents | 3.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 0.00 USD | Marketable Securities, Current |
| Customer receivables | 49.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $3.55M | $383.41K | $3.50M | $0.00 | $49.00K | (m) | 9.26× |
| 2026-02-28 | $5.14M | $214.67K | $5.10M | $0.00 | $42.03K | (m) | 23.95× |
| 2025-11-30 | $4.39M | $1.46M | $4.30M | $0.00 | $88.04K | (m) | 3.01× |
| 2025-08-31 | (m) | $1.49M | (m) | $22.09K | $368.36K | (m) | (m) |
| 2025-05-31 | $4.99M | $1.49M | $4.60M | $33.54K | $358.13K | (m) | 3.35× |
| 2025-02-28 | $6.91M | $1.82M | $6.50M | $73.92K | $331.17K | (m) | 3.79× |
| 2024-11-30 | (m) | $297.80K | (m) | $39.88K | $263.49K | (m) | (m) |
| 2024-08-31 | (m) | $1.10M | (m) | $55.81K | $154.48K | (m) | (m) |
| 2024-05-31 | (m) | $156.05K | (m) | $46.31K | $208.44K | (m) | (m) |
| 2024-02-29 | (m) | $81.72K | (m) | $87.70K | $357.09K | (m) | (m) |
| 2023-11-30 | (m) | $124.52K | (m) | $72.43K | $534.73K | (m) | (m) |
| 2023-08-31 | (m) | $267.74K | (m) | $125.64K | $175.25K | $0.00 | (m) |
| 2023-05-31 | (m) | $1.06M | (m) | $269.56K | $172.28K | $0.00 | (m) |
| 2023-02-28 | $3.68M | $223.13K | $3.27M | $267.70K | $136.80K | $7.59K | 16.48× |
| 2022-11-30 | $5.09M | $281.52K | $4.53M | $269.71K | $286.32K | $9.94K | 18.08× |
| 2022-08-31 | $6.36M | $194.04K | $5.81M | $347.33K | $201.78K | $38.42K | 32.79× |
| 2022-05-31 | $7.49M | $206.83K | $7.05M | $288.03K | $154.87K | $40.18K | 36.23× |
| 2022-02-28 | $9.42M | $165.54K | $8.36M | $552.32K | $506.62K | $31.93K | 56.89× |
| 2021-11-30 | $10.64M | $237.70K | $9.68M | $493.42K | $461.51K | $26.97K | 44.75× |
| 2021-08-31 | $12.09M | $153.28K | $10.92M | $833.84K | $342.40K | $29.65K | 78.90× |
| 2021-05-31 | $9.46M | $221.22K | $8.11M | $400.74K | $954.10K | $51.74K | 42.78× |
| 2021-02-28 | $10.45M | $399.39K | $9.35M | $470.63K | $627.78K | $137.28K | 26.15× |
| 2020-11-30 | $996.40K | $242.47K | $525.34K | $43.73K | $427.33K | $125.96K | 4.11× |
| 2020-08-31 | $1.63M | $225.92K | $1.29M | $19.32K | $313.93K | $116.87K | 7.20× |
| 2020-05-31 | $2.31M | $90.97K | $2.03M | $18.28K | $253.96K | $132.92K | 25.35× |
| 2020-02-29 | $990.87K | $63.29K | $739.99K | $23.62K | $227.27K | $124.41K | 15.66× |
| 2019-11-30 | $1.68M | $130.23K | $1.33M | $22.64K | $325.90K | $133.56K | 12.91× |
| 2019-08-31 | $1.62M | $184.51K | $1.29M | $64.21K | $273.14K | $127.40K | 8.79× |
| 2019-05-31 | $2.30M | $132.29K | $2.00M | $74.84K | $225.83K | $188.28K | 17.36× |
| 2019-02-28 | $3.38M | $500.08K | $3.09M | $71.13K | $219.10K | $108.02K | 6.77× |
| 2018-11-30 | $2.93M | $129.94K | $2.64M | $71.02K | $214.87K | $116.67K | 22.55× |
| 2018-08-31 | $2.00M | $43.64K | $1.73M | $10.15K | $265.75K | $87.23K | 45.90× |
| 2018-05-31 | $2.35M | $71.64K | $2.06M | $17.62K | $267.78K | $76.47K | 32.78× |
| 2018-02-28 | (m) | $69.04K | $2.32M | (m) | $188.28K | $62.53K | (m) |
| 2017-11-30 | (m) | $95.70K | $2.21M | (m) | $71.92K | $77.44K | (m) |
| 2017-08-31 | (m) | $92.35K | $2.53M | (m) | $45.29K | $67.17K | (m) |
| 2017-05-31 | (m) | $40.00K | $2.79M | (m) | $57.40K | $128.38K | (m) |
| 2017-02-28 | (m) | $333.55K | $523.63K | (m) | $23.63K | $143.37K | (m) |
| 2016-11-30 | (m) | $468.55K | $124.25K | (m) | $649.05K | $150.36K | (m) |
| 2016-08-31 | (m) | $433.88K | $93.41K | (m) | $131.08K | $134.72K | (m) |
| 2016-08-28 | (m) | (m) | $93.41K | (m) | (m) | (m) | (m) |
| 2016-05-31 | (m) | $331.54K | $37.10K | (m) | $14.57K | $126.77K | (m) |
| 2016-02-29 | (m) | $284.29K | $40.22K | (m) | $43.66K | $141.44K | (m) |
| 2015-11-30 | (m) | (m) | $84.03K | (m) | $34.83K | $187.83K | (m) |
| 2015-08-31 | (m) | $55.13K | $260.07K | (m) | $31.38K | $167.99K | (m) |
| 2015-08-29 | (m) | (m) | $260.07K | (m) | (m) | (m) | (m) |
| 2015-05-31 | (m) | $62.60K | $832.10K | (m) | $21.63K | $79.34K | (m) |
| 2015-02-28 | (m) | $38.15K | $792.02K | (m) | $35.02K | $77.59K | (m) |
| 2014-11-30 | (m) | $789.36K | $431.07K | (m) | $75.33K | $18.80K | (m) |
| 2014-08-31 | (m) | $918.04K | $703.03K | (m) | $97.00K | (m) | (m) |
| 2014-08-28 | (m) | (m) | $703.03K | (m) | (m) | (m) | (m) |
| 2014-07-31 | (m) | $957.42K | $578.48K | (m) | $98.68K | (m) | (m) |
| 2014-05-31 | (m) | (m) | $877.89K | (m) | (m) | (m) | (m) |
| 2014-04-30 | (m) | $1.05M | $951.74K | (m) | $100.32K | (m) | (m) |
| 2014-02-28 | (m) | (m) | $36.90K | (m) | (m) | (m) | (m) |
| 2014-01-31 | (m) | $1.47M | $28.66K | (m) | $130.65K | (m) | (m) |
| 2013-11-30 | (m) | (m) | $125.19K | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | $1.42M | $65.54K | (m) | $79.22K | (m) | (m) |
| 2013-08-31 | (m) | (m) | $38.91K | (m) | (m) | (m) | (m) |
| 2013-08-28 | (m) | (m) | $65.54K | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | $1.40M | $27.53K | (m) | $151.82K | (m) | (m) |
| 2013-04-30 | (m) | $1.48M | $44.53K | (m) | $167.22K | (m) | (m) |
| 2013-01-31 | (m) | $1.55M | $38.94K | (m) | $239.91K | (m) | (m) |
| 2012-10-31 | (m) | $1.71M | $180.51K | (m) | $290.94K | (m) | (m) |
| 2012-07-31 | (m) | $1.84M | $16.45K | (m) | $497.87K | (m) | (m) |
| 2012-04-30 | (m) | $1.81M | $120.56K | (m) | $139.52K | (m) | (m) |
| 2012-01-31 | (m) | $1.68M | $140.48K | (m) | $176.44K | (m) | (m) |
| 2011-10-31 | (m) | $1.08M | $31.20K | (m) | $230.88K | (m) | (m) |
| 2011-07-31 | (m) | $876.74K | $494.44K | (m) | $231.61K | (m) | (m) |
| 2011-04-30 | (m) | (m) | $126.84K | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | (m) | $279.60K | (m) | (m) | (m) | (m) |
| 2010-10-31 | (m) | $1.05M | $62.99K | (m) | $74.88K | (m) | (m) |
| 2010-07-31 | (m) | (m) | $431.39K | (m) | (m) | (m) | (m) |
| 2009-10-31 | (m) | (m) | $330.17K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |